In the video above, Russel Brand discusses the conflicts of interest that arise when a regulatory agency is funded by the industry it is charged with regulating. Take the U.S. Food and Drug Administration, for example. In years past, the FDA was funded entirely by U.S. taxpayers. Today, nearly 45% of its annual budget comes from user fees paid by the drug companies that seek approval for a given product, Brand says. This transition from public to corporate funding has had a significant impact on how the agency operates, and it’s clearly not in the public’s best interest. Brand cites data showing the FDA has gone from a drug approval rate of 38% in 2005 to 61% in 2018. In situations where a drug is aimed at a disease where few medication options already exist, 89% of new drug applications are approved on the first try. Has drug development simply gotten that much better? Probably not. The fact is that drug companies view the FDA’s user fees as payment for service rendered, and that service includes approval. They’re not paying for the FDA to turn them down. Why FDA and Big Pharma Have a Trust ProblemIn response to the COVID-19 pandemic, the FDA issued emergency use authorizations for completely novel types of “vaccine” in a matter of weeks. While some applaud this speediness, it’s worth remembering that as speedy approvals have increased with other drugs, so have the number found to be harmful after the fact. Data cited by Brand show that 21% of FDA approved medications ultimately had to be removed from the market or be given a black box warning. Essentially, if you’re taking a newly approved drug, the chances that this drug will be found to be extremely dangerous is 1 in 5, which is hardly encouraging! A 2017 Yale study1 found the situation is even more dire than that, showing nearly 1 in 3 FDA approved drugs ends up having new safety issues detected in the years following approval. The FDA is also allowing drug makers to profit at the expense of public health by allowing them to “claim success in trials based on proxy measurements instead of clinical outcomes like survival rates or cures, which take more time to evaluate,” Caroline Chen notes in a June 2018 ProPublica article.2 FDA Advisers Receive Payouts to Approve DrugsIn addition to that, “pay-later conflicts of interest” are widespread, according to an investigation by the journal Science.3 This is when doctors who advise the FDA or sit on drug panels that are in charge of drug approval are paid by drug makers AFTER the approval is a done deal. Science examined 107 physician FDA advisers who voted on drug approvals. Of those, 40 ended up receiving more than $10,000 in post hoc earnings from the drug company whose drug they voted to approve; 26 of them got more than $100,000 and six were paid more than $1 million. FDA advisers who help drug makers gain approval also reap rewards in other ways. As noted by Science:4
FDA Has Already Lost Most of Its CredibilityAs argued by Brand, the data is rather unequivocal. It tells us corruption is rampant and the FDA has completely abandoned its charter to ensure public health and safety. It’s really just there to give the appearance that someone is looking out for public health, while in actuality it’s a venue through which drug makers are enabled to profit from unsafe and unproven drugs. The sad reality is that while FDA approval used to mean something, today it has basically lost all meaning. Just because a drug is FDA-approved doesn’t mean it’s been proven safe and effective. Again and again, drugs are found to have serious safety issues in the years after their approval. As a result, drug companies are allowed to benefit while public health is sacrificed, which is precisely the situation that the FDA was created to prevent. FDA Approves COVID Boosters for SeniorsSeptember 17, 2021, the FDA approved the Pfizer-BioNTech COVID shot Comirnaty as a third-dose booster for people over the age of 65 and other high-risk individuals. As reported by The Vaccine Reaction September 19, 2021:5
At the end of the day, 16 of the 18 VRBPAC members voted “no” on approving a Comirnaty booster dose for people over the age of 16. A second vote was then hastily thrown together, after members indicated they’d be comfortable recommending a booster for seniors and “people at high risk of severe COVID-19,” which the FDA is defining as health care workers and those at increased risk of exposure due to their occupation. This unscheduled second vote passed unanimously. However, as reported by The Vaccine Reaction:6
What’s more, the FDA suddenly shifted from “individuals at high risk of severe COVID-19” infection, to having it apply to “health care workers or others at high risk of occupational exposure.”
In a September 19, 2021, appearance on CBS News,8 director of the National Institutes of Health Dr. Francis Collins stated he fully expects the FDA to extend boosters beyond seniors aged 65 and older, health care workers and others at high risk of occupational exposure. 1 in 1,000 mRNA Shots Results in Heart InflammationSo, the FDA claims the Pfizer shot is safe and effective enough to warrant a third booster for certain groups. But is it? According to a retrospective study9,10 by the University of Ottawa Heart Institute, 1 in 1,000 mRNA injections (Pfizer and Moderna) have resulted in myopericarditis, i.e., inflammation of the heart or heart sack, within one month of the shot, although symptom onset typically occurred within days. The study was posted on the preprint server medRxiv September 16, 2021, the day before the FDA voted “yes” on boosters for the elderly and certain high-risk groups. As explained by the authors:11
COVID Shots May Be Killing Two for Every Life SavedAccording to expert testimony given during the September 17, 2021, FDA Vaccine Advisory Committee meeting (see video above),12 the shots may in fact be killing far more people than they’re saving. According to Dr. Joseph Fraiman, an emergency medicine physician in New Orleans, there’s no clinical evidence to prove the COVID shots are saving more people than they harm. He told the committee they ought to:
Steve Kirsch, executive director of the COVID-19 Early Treatment Fund, then went on to show what Fraiman feared the most, namely that the Pfizer shot kills two people for every person it saves.
Here’s a screenshot from Kirsch’s slide show, showing the number of people killed by the COVID shots, compared to the number of lives saved by them. Kirsch went on to state that while the VAERS data is the only data that are statistically significant, the other two data sources are still “troubling”:
Kirsch also showed data suggesting 1 in 317 boys aged 16 to 17 will get myocarditis from the shots, and after a third booster, that number may reach as high as 1 in 25. He also points out that Pfizer’s Phase 3 trials must clearly be “gamed,” as “it is statistically impossible for protocol violations to be five times higher in the treatment group.” “Why has this not been investigated?” he asked. What Do the VAERS Data Tell Us?In a September 18, 2021, interview with The Covexit podcast, Jessica Rose, Ph.D., who holds degrees in applied mathematics, immunology, computational biology, molecular biology and biochemistry, discussed what the U.S. Vaccine Adverse Events Reporting System (VAERS) data tell us about the safety of the COVID shots. Rose covers issues such as the magnitude of the side effects compared to other vaccination programs, the problem of under-reporting, and how causality can be assessed using the Bradford Hill Criteria. You can find a PDF of the slide show that Rose presents here.13 Here’s a summary of some of the key points made in this interview:
Children Are Now the Next TargetWhile the FDA voted against recommending a third booster to young adults aged 16 and over, there’s little doubt that the recommendation will soon be expanded to people under the age of 65, and eventually even young children.14 I say that because there seems to be no ceiling above which the death and disability toll is deemed too great. Why? We have not been given a straight answer, leaving us to speculate about the FDA’s intentions. Why aren’t they concerned about safety when more than half a million side effect reports have been filed? How come nearly 15,000 reported deaths15 haven’t set off emergency alarms and in-depth investigations? As noted by Rose, 50 deaths have historically been the cutoff point at which a vaccine is pulled. We’re so far beyond that now, it seems there’s no threshold anymore. At present, one wonders whether the FDA’s reluctance to approve a booster for younger individuals is mere show. Perhaps they’re trying to reclaim some measure of scientific authority, which was undermined by the U.S. government and Pfizer announcing the release of boosters before the FDA had even made its determination. Whatever the case may be, I urge you to review as much data as you can before you jump on the booster bandwagon. Based on everything I’ve seen, I believe the risk of side effects is likely going to exponentially increase with each dose. If you need a refresher on the potential mechanisms of harm, download and read Stephanie Seneff’s excellent paper,16 “Worse Than The Disease: Reviewing Some Possible Unintended Consequences of mRNA Vaccines Against COVID-19,” published in the International Journal of Vaccine Theory, Practice and Research in collaboration with Dr. Greg Nigh. from http://articles.mercola.com/sites/articles/archive/2021/09/27/covid-jabs-killing-two-people-for-every-person-saved.aspx
0 Comments
Leave a Reply. |
Nia Pure NatureThe Provider of premium Quality Health Products To Live Better Lives Archives
March 2022
Categories |